Associations between lifetime classic psychedelic use and cardiometabolic diseases

Respondents who reported having tried a classic psychedelic at least once in their lifetime had lower odds of heart disease in the past year

Previous
Previous

Australian Therapists to Be Given Psilocybin to Better Understand Their Patients

Next
Next

Psychedelic research renaissance: The urgent quest for new mental health medicines